Meeting Report and Proceedings: Multiple Sclerosis Society of Great Britain and Northern Ireland

1 Komoly S et al. (1992) Proc Nat Acad Sci USA 89: 1894–1898.

2 Liu X et al. (1994) Mol Cell Neurosci 5: 418–430.

3 Yao D-L et al. (1995) J Neurosci Res 40: 647–659.

4 Liu X et al. (1995) Mult Scler 1: 2–9.

5 Yao D-L et al. (1995) Proc Natl Acad Sci USA 92: 6190–6194.

6 Yao D-L et al. Life Sci (submitted for publication).

1 Kennedy MK , Torrance DS , Picha KS , Mohler KM . (1992) Analysis of cytokine mRNA expression in the CNS of mice with EAE reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149: 2496–2505.

2 Woodroof e MN , Cuzner ML . (1993) Detection of cytokine mRNAs in multiple sclerosis brain tissue by non-radioactive in situ hybridisation. Cytokine 5: 583–588.

3 Hayes GM , Woodroof e MN , Cuzner ML . (1988) Microglia express MHC class II in normal and demyelinating human white matter. Ann. NY Acad. Sci. 540: 501–503.

4 Woodroof e MN et al. (1991) Detection of IL-1 and IL-6 in adult rat brain following mechanical injury. Evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33: 227–236

5 Woodroof e MN . (1995) Cytokine production in the CNS. Neurology 45: 6–10

1 de Pablo F , de la Rosa EJ . (1995) The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors. TINS 18: 143–150.

2 Liu X et al. (1994) Astrocytes express insulin-like growth factor-1 (IGF-1) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis. Mol. Cell Neurosci. 5: 418–430.

3 Yao DL , Liu X , Hudson LD , Webster HD . (1996) Insulin-like growth factor-I given subcutaneously reduces clinical deficits, decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitis. Life Sci 58: 1301–1306.

4 Newcombe J, Cuzner ML. (1993) Organisation and research applications of the U.K. Multiple Sclerosis Society Tissue Bank. In: How to Run a Brain Bank, Eds. Cruz-Sánchez FF and Tolosa E. J. Neural. Trans. (Suppl) 39: 155–163.

5 Li H , Newcombe J , Groome N , Cuzner ML . (1993) Characterisation and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 19: 214–223.

1 Ager A . (1994) Trends Cell Biol 4: 326–333.

2 Bargatze RF , Jutila MA , Butcher EC . (1995) Immunity 3: 99–108.

3 Springer TA . (1994) Cell 76: 301–314.

4 Butcher EC . (1991) Cell 67: 1033–1066

5 Hourihan H , Allen TD , Ager A . (1993) J Cell Sci 104: 1049–1059

6 Giraud JP , Springer TA . (1995) Immunol Today 16: 449–457.

1 Allen IV , Glover G , Anderson R . (1981) Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis. Acta Neuropathologica. Suppl 7: 176–178.

2 Raine CS , Traugott U . (1990) The pathology of the demyelinated axon. In: Current Trends in Neurosciences-Neuromuscular diseases (Eds. Adachi M and Sher JH ). Igaku-Shoin, New York. 229–275.

3 Hafler DA , Weiner HL . (1987) In vivo labelling of blood T cells: rapid trafficking to cerebrospinal fluid in multiple sclerosis. Ann. Neurol. 22: 89–93.

4 Sobel RA . (1995) The pathology of multiple sclerosis. Neurologic Clinics Multiple Sclerosis. 3: 1–21.

5 Allen IV , McQuaid S , McMahon J , Crangle K , McConnell R . (1996) The expression of the endothelial cell antigen CD34 in demyelinating disease. Neuropathology & Applied Neurobiology 22: 101–107

1 Hynes RO , Lander AD . (1992) Cell 68, 303–322.

2 Colton CA , Keri JE , Chen W-T , Monsky WL . (1993) J. Neurosci. Res. 35, 297–304.

3 Romanic AM , Madri JA . (1994) Brain Pathology 4, 145–156.

4 Chantry A , Gregson NA , Glynn P . (1989) J. Biol. Chem. 264, 21603–21607.

5 Yamada T et al. (1995) Acta Neuropathol. 89, 199–203.

1 Allen IV , Glover G , Anderson R . (1981) Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis. Acta Neuropathologica suppl 7: 176–178.

2 Gearing JH , Newman W . Circulating adhesion molecules in disease. Immunol Today 1993: 14: 506–512.

3 Dore-Duffy P et al. (1995) Circulating soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann Neurol 37: 55–62.

1 Calder V , Greenwood J . (1995) Role of the vascular endothelium in immunologically-mediated neurological disease. In: Immunological aspects of the vascular endothelium. C. Savage and J. Pearson (Eds) Cambridge University Press, pp 96–123.

2 Greenwood J , Calder V . (1993) Lymphocyte migration through cultured endothelial cell monolayers derived from the blood-retinal barrier. Immunology. 80: 401–406.

3 Greenwood J , Wang Y , Calder V . (1995) Lymphocyte adhesion and transendothelial migration in the CNS: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. Immunology 86: 408–415.

4 Durieu-Trautmann O , Chaverot N , Cazaubon S , Strosberg AD , Couraud PO . (1994) Intracellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J Biol Chem. 269: 12536–12540.

5 Ridley AJ , Hall A . (1992) The small GTP-binding protein rho regulates the assembly offocal adhesions and actin stress fibres in response to growth factors. Cell 70: 389–399.

1 Male DK , Rahman J , Linke A , Zhao W , Hickey W . (1995) An Interferon-inducible molecule on brain endothelium which controls lymphocyte adhesion mediated by integrins. Immunology. 84: 453–460.

1 Stevenson P, Hawke S, Bangham C. (1996) Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory cells, (submitted for publication)

1 Asipu A , Blair GE . (1994) Gene 150: 227–234.

2 Wrabetz L et al. (1993) J. Neurosci. Res. 36: 455–471.

3 Barrett G et al. (1992) Proc. Natl. Acad. Sci. USA 89: 885–889.

4 Sujita K , Miyazaki J , Appella E , Ozato K . (1987) Mol. Cell. Biol. 7: 2625–2630.

5 Rutherford MN , Hannigan GE , Williams BRG . (1988) EMBO J. 7: 751–759.

6 Srehlow I , Decker T . (1992) Nucleic Acids. Res. 20: 3865–3872.

1 Griffiths TD , Newman PK . (1985) J Clin Pharm & Therapeut 19: 219–222.

2 Hommes O et al. (1995) Interferon-beta in the treatment of multiple sclerosis. Multiple Sclerosis 1 (Suppl 1): 1–69.

1 Bö L. et al. (1994) Ann Neurol. 36: 778–786

2 Johnson AW et al. (1995) J Neurol Neurosurg Psychiat 58: 107.

3 Bolaños JP , Heales SJR , Land JM , Clark JB . (1995) J. Neurochem 64: 1965–1972.

4 Mitrovic B et al. (1994) Neurosci. 61: 575–585.

1 Moreau T , Thorpe J , Miller D , Moseley I , Hale G , Waldmann H , Clayton D , Wing M , Scolding N , Compston A . (1994) Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. Lancet 344: 298–301.

1 Ebers GG , Bulman DE , Sadovnick AD et al. (1986) New Engl J Med 315: (26): 1638–42.

2 Mumford CJ , Wood NW , Kellar-Wood HF et al. (1994) Neurology 44: 11–15.

3 Selmaj K , Raine CS , Cannella B , Brosnan CF . (1991) J Clin Invest 87: 949–54.

4 Udalova IA , Nedospasov SA , Webb GC et al. (1993) Genomics 16: 180–86.

5 Kirk CW , Droogan AG , Hawkins SA et al. (1995) J Neurology 242 (6) Supp. 2.: 22.

1 EJ Redford , SM Hall , KJ Smith . (1995) Brain, 118: 869–878

1 Leonard JP , Waldburger KE , Golman SJ . (1995) Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12. J Exp Med 181: 381–386.

1 Moreau JF et al. (1988) Nature 336: 690–692.

2 Blanco G et al. (1993) Transplant Proc 25: 891–892.

3 Hirano T et al. (1990) Immunol Today 11: 443–449.

4 Godard A et al. (1992) J Biol Chem 267: 3214–3222.

5 Nawa H , Patterson PH . (1990) Neuron 4: 269–277.

6 Curtis R et al. (1994) Neuron 12: 191–204.

1 Woodroof e MN , Cuzner ML . (1993) Cytokine 5: 583–588.

2 Baker D , O'Neill JK , Turk JL . (1991) Cell Immunol 134: 505–510.

3 Paya CV, Leibson PJ, Patick AK, Rodriguez M. (1990) 2: 909–913.

4 Kelly WR , Blakemore WF , Jagelman S , Webb HE . (1982) Neuropathology and Applied Neurobiology 2: 43–53.

1 Laposata M (1995) Am J Clin Path 104: 172.

2 Harbige L (1995) Nutr Health 10: 285.

3 Harbige LS , Yeatman N , Amor S , Crawford MA . (1995) Br J Nutr 74: 701.

4 Amor S et al. (1994) J Immunol 153: 4349.

1 Baker D et al. (1990) J Neuroimmunol 28: 261–270.

2 Baker D et al. (1994) Eur. J. Immunol 24: 2040–2048

1 Raine CS (1991) Multiple Sclerosis: a Pivotal Role for the T cell in Lesion Development. Neuropath App Neurobiol 17: 265–274.

2 Lindsey JW et al. (1994) Repeated treatment with Chimeric Anti-CD4 antibody in multiple sclerosis. Ann Neurol 36: 183–189.

1 Sternberg EM et al. (1989) Proc. Natl. Acad. Sci. USA. 86: 4771.

2 Mason DW , MacPhee I , Antoni F . (1990) Immunology 70: 1.

3 MacPhee IAM , Antoni FA , Mason DW . (1989) J Exp Med 169: 341.

4 Mason D . (1991) Immunol Today 12: 57.

5 Daynes RA , Araneo BA . (1989) Eur J Immunol 19: 2319.

6 Wu CY-C , Fargeas T , Nakajima , Delespesse G . (1991) Eur J Immunol. 21: 2645.

1 Smith RM , Morgan A , Wraith DC . (1994) Anti-class II MHC antibodies are able to prevent and treat EAE without APC depletion. Immunology 83: 1–8.

2 Linnington C . (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130: 443–54.

1 Baker D et al. (1994) Control of established EAE by inhibition of TNF activity within the CNS using monoclonal antibodies and TNF-R-Ig fusion proteins. Eur J Immunol 24: 2040–2048.

2 Kolls J , Peppel K , Silva M , Beutler B (1994) Prolonged and effective blockade of TNF activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91: 215–219.

3 Neve R et al. (1996) Expression of an efficient small molecular weight TNF/lymphotoxin inhibitor. Cytokine (in Press):

4 Butler D et al. (1994) TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-1D4 rhabdomyosarcoma cells. Cytokine 6: 616–623.

1 Kalaria RN et al. (1992) Acta Neuropathol 84: 606–12.

2 Norton J et al. (1993) J Pathol 170: 173–7.

3 Delia D et al. (1993) Blood 81: 1001–8.

4 Allen IV et al. (1996) Neuropathol & Appl Neurobiol 22: 101–107

1 Huber C et al. (1984) Immune response-associated production of neopterin. Release of neopterin from macrophage primarily under the control of interferon-gamma. J Exp Med 160: 310–6.

2 Kwon NY et al. (1989) Reduced biopterin as a cof actor in the generation of nitrogen oxides by murine macrophages. J Biol Chem 264: 20496–501.

3 Fredrickson S et al. (1987) CSF neopterin as marker of disease activity in multiple sclerosis. Acta Neurol Scand 75: 352–5.

4 Ott M et al. (1993) Interleukin-2, soluble interleukin-2–receptor, neopterin, L-tryptophan and β2-Microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis. J Neurol 241: 108–14.

5 Sibley WA et al. (1985) Clinical viral infections and multiple sclerosis. The Lancet 1: 1313–5.

6 Panitch H . (1994) Influence of infection on exacerbations of multiple sclerosis. Ann Neurol 36: S25–8.

1 Johnson AW et al. (1995) Evidence for increased nitric oxide production in multiple sclerosis. J Neurol Neurosurg Psychiatry 58: 107.

2 Bo L et al. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36: 778–86.

3 Merrill JE et al. (1993) Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151: 2132–41.

4 Bolanos JP et al. (1995) Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J Neurochem 64: 1965–72.

5 Cross AH et al. (1994) Aminoguanidine, an inhibitor of inducible nitric-oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 93: 2684–90.

6 Zangerle R et al. (1995) Serum nitrite plus nitrate in infection with human immunodeficiency virus type-1. Immunobiol 193: 59–70.

1 Amor S et al. (1994) J. Immunol 153: 4349.

2 Pelfrey CM , Trotter JL , Tranquill L , McFarland HF . (1993) J. Neuroimmunol 46: 33

1 Miller DH et al. (1991) J Neurol Neurosug Psychiatry 54: 683–688.

2 IFNB Multiple Sclerosis Study Group et al . (1995) Neurology 45: 1277–1285.

3 Rydberg JN et al. (1994) Radiology 193: 173–180.

4 Permock JM et al. (1993) Proc. SMR 331. (Abstract)

5 Thorpe JW et al. (1994) Lancet 344: 1235.

1 Kidd D et al. (1993) Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43: 2632–2637.

2 Losseff NA et al. (1995) The prognostic value of serial axial cord area measurement by magnetic resonance imaging in multiple sclerosis. J Neurol 242 (Suppl 2): S 110. (Abstract)

3 Filippi M et al. (1995) A spinal cord MRI study of benign and secondary progressive multiple sclerosis. SMRM 1: 277. (Abstract)

1 Losseff NA , Miller DH , McDonald WI et al. (1995) Spinal cord atrophy: a sensitive and reproducible measure of disease progression in multiple sclerosis. Journal of Neuroimmunology Suppl. 1: 53. (Abstract)

2 Davie CA , Barker GJ , Webb S et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995 (in press)

1 Morrissey SP , Miller DH , Kendall BE et al. (1993) The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain, 116: 135–46.

2 Ormerod IEC , Bronstein A , Rudge P et al. (1986b) Magnetic resonance imaging in clinically isolated lesions of the brain stem. Journal of Neurology, Neurosurgery and Psychiatry, 49: 737–43.

3 Rizzo JF , Lessell S . (1988) Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology, 38: 185–90.

1 Dousset V et al. (1982) Radiology 182: 483–491.

2 Gass A et al. (1994) Ann Neurol 36: 62–67.

3 Oppenheimer DR . (1978) Neuropathology and Applied Neurobiology 4: 151–162.

4 Kidd D et al. (1993) Neurology 43: 2632–2637.

5 Losseff NA et al. (1995) Journal of Neuroimmunology, Supplement 1: 53.(abstract).

6 Turano G , Jones SJ , Miller DH . (1991) Brain 114: 663–681.

1 Neurourol Urodyn 1992; 11: 327–328

2 Neurourol Urodyn 1994; 13: 349–350

3 ST Hasan . J Urol 1996 (in press)

1 Jones SJ . (1993) Visual evoked potentials after optic neuritis: effect of time interval, age and disease dissemination. Journal of Neurology 240: 489–494.

2 Miller DH , Newton MR , van der Poel JC , du Boulay EPGH , Halliday AM , Kendall BE , Johnson G , MacManus DG , Moseley IF , McDonald WI . (1988) Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology 38: 175–179.

1 Haegart DG et al. (1993) Neurology 43: 548

2 Todd JA , Bell JI , McDevitt HO . (1987) Nature 329: 599

3 Baker D et al. (1990) J. Neuroimmunol 28: 261

4 Amor S et al. (1994) J. Immunol 153: 4349

5 Amor S , Baker D , Groome N , Turk JL . (1993) J Immunol 150: 5666

1 Amor S , Baker D , Groome NP , Turk J . (1993) J Immunol 150: 566–567

2 Amor S , Groome NP et al. (1994) J Immunol 153: 4349–4356

3 Yon SM , White P , Groome NP . (1995) J Neuroimmunol 58: 121–129.

4 Gott A , Malloon B , Paton A , Groome NP , Rumsby M . (1994) Neuroscience letters 171: 117–120.

5 Groome NP. (1995) In Synthetic Peptide Antigens Practical Approach Series IRL press. Ed. Wisdom. B pp 139–179.

6 Groome NP et al. (1995) J Clin Endocrinol. Metab 80: 2926–2932.

1 Metzler B , Wraith DC . (1993) Intern Immunol 5: 1159–1165

2 Metzler B , Wraith DC . (1996) Ann NY Acad Sci. (in press)

3 Lui, GY Fairchild PJ et al. (1995)

1 Amor S , Scallan M , Morris MM , Dyson H , Fazakerley JK . (1996) Role of immune responses in protection and pathogenesis during semliki forest virus infection. J. Gen. Virol 77 (in press)

2 Fazakerley JK , Pathak S , Scallan M , Amor S , Dyson H . (1993) Replication of the A7(74) strain of Semliki Forest virus is restricted to neurons. Virology 195: 627–637.

1 Brankin B , Hart MN , Cosby SL , Fabry Z . (1995) Adhesion molecule expression and lymphocyte adhesion to cerebral endothelium: effects of measles virus and herpes simplex 1 virus. J Neuroimmunol 56: 1–8.

1 Fazakerley JK , Buchmeier MJ . (1993) Pathogenesis of virus-induced demyelination. Adv Vir Res 42: 249–324

2 Simas JP , Dyson M , Fazakerley JK . (1995) The neurovirulent GDVII strain of Theiler's virus can replicate in glial cells. J Virol 69: 5599–5606.

1 Linsley PS , Ledbetter JA . (1993) The role of the CD28 receptor during T cell responses to antigen. Ann Rev Immunol 11: 191.

2 Jenkin MK (1994) The ups and downs of T cell costimulation. Immunity 1: 443–446.

3 Newcombe J, Cuzner ML. (1993) Organization and research applications of the U.K. Multiple Sclerosis Society Tissue Bank. In: How to Run a Brain Bank, Eds. F.F. Cruz-Sanchez and E. Tolosa. J. Neural. Trans. Suppl. 39: 155–163.

4 Li H , Newcombe J , Groome N , Cuzner ML . (1993) Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 19: 214–23.

5 Windhagen A et al. (1995) Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and IL-12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182: 1985–1996.

1 Weller RO , Kida S , Zhang ET . (1992) Pathways offluid drainage from the brain — morphological aspects and immunological significance in rat and man. Brain Pathol 2: 277–284.

2 Knopf PM et al. (1995) Physiology and immunology of lymphatic drainage of interstitial and cerebrospinal fluid from the brain. Neuropathology and Applied Neurobiology, 21: 175–180.

3 Zhang ET , Richards HK , Kida S , Weller RO . (1992) Directional and compartmentalised drainage of interstitial fluid and CSF from the rat brain. Acta Neuropathologica; 83: 233–239.

4 Kida S , Pantazis A , Weller RO . (1993) CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropathology and Applied Neurobiology, 19: 480–488.

5 Phillips MJ , Weller RO , Kida S , Iannotti F . (1995) Focal brain damage enhances experimental allergic encephalomyelitis in brain and spinal cord. Neuropathology and Applied Neurobiology, 21: 189–200.

1 Schmeid M et al. (1993) Apoptosis of T-lymphocytes in experimental allergic encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 143: 446–452.

1 P Gasque et al (1992) J Immunol 149: 1381–1387.

2 P Gasque et al (1993) J Biol Chem 268: 25068–25074.

3 P Gasque et al (1995) J Immunol 154: 4726–4733.

4 P Gasque et al (1995) J Immunol (in press.)

1 Murphy G , Docherty AJP . (1992) The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol. 7: 120–125.

2 Proost P , Van Damme J , Opdenakker G . (1993) Leukocyte gelatinase β cleavage releases encephalitogens from human myelin basic protein. Biochem. Biophys. Res. Comm. 192: 1175–1181.

3 Gijbels K , Galardy RE , Steinman L . (1994) Reversal of experimental allergic encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94: 2177–2182.

4 Norga K , Paemen L , Masure S , Dillen C , Heremans H , Billiau A , Carton H , Cuzner L , Olsson T , Van Damme J , Opdenakker G . (1995) Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine. Inflammation Res. (In press)

5 Hewson AK , Smith T , Leonard JP , Cuzner ML . (1995) Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31–9790. Inflammation Res. 44: 345–349

1 Matyszak M , Perry VH . (1995) Demyelination in the central nervous system following a delayed-type hypersensitivity response to Bacillus calmette-guerin. Neuroscience 64: 967–977.

1 Weller RO , Kida S , Zhang ET . (1992) Pathways offluid drainage from the brain — morphological aspects and immunological significance in rat and man. Brain Pathol 2: 277–284.

2 Knopf PM , Cserr HF , Nolan SC , Wu T-Y , Harling-Berg CJ . (1995) Physiology and immunology of lymphatic drainage of interstitial and cerebrospinal fluid from the brain. Neuropathology and Applied Neurobiology, 21: 175–180.

3 Zhang ET , Richards HK , Kida S , Weller RO . (1992) Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain. Acta Neuropathologica 83: 233–239.

4 Kida S , Pantazis A , Weller RO . (1993) CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropathology and Applied Neurobiology, 19: 480–488.

5 Phillips MJ , Weller RO , Kida S , Iannotti F . (1995) Focal brain damage enhances experimental allergic encephalomyelitis in brain and spinal cord. Neuropathology and Applied Neurobiology, 21: 189–200.

1 Piddlesden SJ , Lassmann H , Zimprich F , Morgan BP , Linington C . (1993) The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J. Pathol. 143: 555–564.

2 Loughlin A , et al. (1994) Myelin basic protein content of aggregating rat brain cell cultures treated with cytokines and/or demyelinating antibody. Effects of macrophage enrichment. J. Neurosci. Res. 37: 647–633.

1 Matyszak MK , Perry VH . (1995) Demyelination in the central nervous system following a delayed-type hypersensitivity response to Bacillus Calmette-Guerin. Neuroscience 64: 967–977.

1 Bauerle PA , Henkel T . (1994) Function and activation of NF-KB in the immune system. Ann. Rev. Immunol. 12: 141–179.

2 Auphan N , DiDonato JA , Rosette C , Helmberg A et al. (1995) Immunosuppression by glucocorticoids: Inhibition of NF-KB activity through induction of IKB synthesis. Science 270: 286–290.

3 Kaltschmidt C , Kaltschmidt B , Lannes-Vieira J , Kreutzberg GW et al. (1994) Activation of the transcription factor NF-KB is induced in microglia during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 55: 99–106.

4 Newcombe J, Cuzner ML (1993) Organisation and research applications of the U.K. Multiple Sclerosis Society Tissue Bank. In: How to Run a Brain Bank; Eds. FF Cruz-Sánchez and E Tolosa. J. Neural. Trans. (Suppl) 39: 155–163.

5 Li H , Newcombe J , Groome N , Cuzner ML (1993) Characterisation and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 19: 214–223.

1 Blakemore WF . (1976) Invasion of Schwann cells into the spinal cord of the rat following injections of lysolecithin. Neuropathology and Applied Neurobiology 2: 21–39.

2 Blakemore WF , Patterson RC . (1978) Suppression of remyelination in the CNS by x-irradiation. Acta Neuropathologica 42: 105–113.

3 Franklin RJM , Bayley SA , Blakemore WF . (1996) Transplanted CG4 cells (an oligodendrocyte progenitor cell line) survive, migrate and contribute to repair of areas of demyelination in X-irradiated and damaged spinal cord, but not in normal spinal cord. Experimental Neurology (in press).

1 Raine CS . (1991) Neuropathol. Appl. Neurobiol 17: 265–274

2 Butt AM , Jenkins HG . (1994) J. Neuroimmunol 51: 27–33

3 Berry M et al. (1996) J. Neurocytol. (in press)

4 Butt AM et al. (1995) Glia 14: 185–197

5 Ibrahim M et al. (1995) J. Neurol. Sci. 133: 119–127

1 Timsit SG et al. (1992) Journal of Neurochemistry 58, 1172–1175

2 Ikenaka K et al. (1992) Journal of Neurochemistry 58, 2248–2253

3 Yu W et al. (1994) Neuron 12, 1353–1362.

4 Timsit S et al. (1995) Journal of Neuroscience 15, 1012–1024.

5 Nadon NL et al. (1990) Development 110, 529–537

6 Schneider et al. (1992) Nature 358, 758–760.

1 Scolding NJ et al. (1989) Myelin oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation. J Neuroimmunol 22: 169–176.

2 Ida H , Kawame F , Kim SU , Eto Y . (1990) Abnormality in cultured oligodendrocytes and Schwann cells isolated from the twitcher mouse. Mol Chem Neuropathol 1990; 13: 195–204.

1 Yamomoto Y et al. (1994) J. Biol Chem 269, 31725–31730

1 Orian JM et al. (1994) Insertional mutagenesis inducing hypomyelination in transgenic mice J Neurosci Res 39: 604–612.

1 Meeson AP , Piddlesden S , Morgan BP , Reynolds R . (1994) Exp. Neurology 129, 299–310.

2 Reynolds R , Wilkin GP . (1993) J. Neurosci. Research 36, 417–434.

1 Baker D , O'Neill JK , Gschmeissner SE , Wilcox CE , Butter C , and Turk JL . (1990) J. Neuroimmunol 28: 261–270.

2 O'Neill JK , Baker D , Turk JL . (1992) J. Neuroimmunol 41: 177–188.

3 O'Neill JK , Baker D , Davison AN , Allen SJ , Butter C , Waldmann H , Turk JL . (1993) J. Neuroimmunol 45: 1–14.

1 Hawkins CP et al. (1990) Brain 113: 365–378.

2 Paul C , Bolton C . (1994) J Neuroimmunol, 54: 188.

3 Paul C , Bolton C . (1995) Int J Immunopharmacol 17: 497–503.

4 Koenig H , Trout JJ , Goldstone AD , Lu CY . (1992) Brain Res 588: 297–303.

5 Ryffel B . (1993) Biochem. Pharmacol. 46: 1–12

6 Bolton C et al. (1994) J Neuroimmunol, 52: 113.

1 Barclay AN , Birkland ML , Brown MH , Beyers AD , Davis SJ , Somoza C , Williams AF . (1993) The leucocyte antigen factsbook. Academic Press, London. 110–111.

2 Webb M , Mason DW , Williams AF . (1979) Inhibition of mixed lymphocyte response by a monoclonal antibody specific for a rat T lymphocyte subset. Nature: 282: 841–843.

3 Brostof f, SW , Mason DW . (1986) The mechanism of inhibition of experimental allergic encephalomyelitis in the rat by monoclonal antibody against CD4. J. Neuroimmunol. 13: 217–232.

4 Stumbles PA , Mason DW . (1995) Activation of CD4+ T cells in the presence of a non-depleting monoclonal antibody to CD4 induces a Th2-type response in vitro. J. Exp Med. 182: 5–13.

1 Lawrence SK , Karlsson L , Price J , Wuaranta V , Ron Y , Sprent J , Peterson PA . (1989) Cell 58: 583.

2 Takacs K , Douek DC , Altmann DM . (1995) Eur J. Immunol. 25: 3134.

1 Polman et al. (1994) Arch. Neurol., 51: 1136–1139.

2 Murray NMF , Newsora-Davis J . (1981) Neurology (Ny), 31: 265–271.

3 Lees G , Leach MJ . (1993) Brain Res 612: 190–199.

4 Watts AE , Jeffrys JG . (1993) Br J Pharmacol 108: 819–823.

5 Eng DL et al. (1988) J Neurophysiol 60: 2168–2179.

6 Bowe CM et al. (1987) Annals of Neurology, 22: 264–268.

1 Felts PA , Kapoor R , Smith KJ . (1995) A mechanism for ectopic firing in central demyelinated axons. Brain 118: 1225–1231.